
Ophthalmologist

No OPD information available
Glaucoma
Ocular Hypertension (OHT)
Age-Related Macular Degeneration (ARMD)
Anton Syndrome
Ganglion Cyst
Medium-Chain Acyl-CoA Dehydrogenase Deficiency
Pigment-Dispersion Syndrome
Marc G. Sarossy is a male healthcare provider who specializes in treating eye conditions like glaucoma, ocular hypertension, age-related macular degeneration, and other eye-related issues. He also helps patients with Anton Syndrome, ganglion cysts, medium-chain acyl-CoA dehydrogenase deficiency, and pigment-dispersion syndrome.
Marc G. Sarossy uses special skills and treatments to help patients with their eye problems. He communicates with patients in a way that makes them feel comfortable and builds trust. Patients trust him because he listens to their concerns and explains things clearly.
To stay updated with the latest medical knowledge, Marc G. Sarossy regularly reads medical journals and attends conferences. He values learning and improving his skills to provide the best care for his patients.
Marc G. Sarossy works well with his colleagues and other medical professionals. He collaborates with them to ensure that patients receive comprehensive care. His approach to teamwork and communication helps in delivering effective treatment plans.
Through his work, Marc G. Sarossy has positively impacted many patients' lives. His dedication to providing quality care has improved the health and well-being of those he treats. Patients have shared stories of how his treatments have helped them see better and live more comfortably.
One of Marc G. Sarossy's notable publications is "High-Resolution Microperimetry for Detecting Glaucomatous Damage: A Prospective Evaluation of Performance" in Clinical & Experimental Ophthalmology. He has also been involved in clinical trials to enhance the management of eye conditions like choroidal neovascular membranes.
In summary, Marc G. Sarossy is a skilled and compassionate healthcare provider who goes above and beyond to help his patients with eye-related issues. His commitment to staying updated with medical knowledge, working well with colleagues, and making a positive impact on patients' lives sets him apart in the field of eye care.
Enrollment Status: Terminated
Published: February 05, 2019
Intervention Type: Device
Study Drug:
Study Phase:
